Vascular Patches Market, by Type (Biologic Vascular Patches and Synthetic Vascular Patches), by Application (Carotid Endarterectomy, Aortic Aneurysms, Profundaplasty, and Others), by End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Vascular patches are used for reconstruction of a damaged artery in the cardiovascular surgeries. It is usually placed at the site infection, which helps in reconstruction and maintenance of carotid arteries in postoperative wound infection. The vascular patches allows positive and safe angioplasty of an artery to be performed in an infected operation site.
Market Dynamics
Rising aging population is expected to drive the global vascular patches market growth. For instance, according to an article published by the World Health Organization (WHO) in February 2018, the proportion of the worldwide geriatric population will nearly double from 12% to 22% between 2015 and 2050.
Moreover, the rising prevalence of cardiovascular diseases is expected to drive the market growth. For instance, according to an article titled ‘Heart Disease and Stroke Statistics-2021’, published by the American College of Cardiology Foundation in 2021, around 795,000 U.S. populace have new or recurrent stroke annually, in which 90.0% of stroke risk is due to modifiable risk factors and 74.0% is due to behavioral risk factors.
researched
medicinal properties of cannabis and its derivatives are widely
researched
medicinal properties of cannabis and its derivatives are widely
researched
medicinal properties of cannabis and its derivatives are widely
researched
medicinal properties of cannabis and its derivatives are widely
researched
Key features of the study:
This report provides in-depth analysis of the global vascular patches market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global vascular patches market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include B. Braun Melsungen AG, C. R. Bard, Inc., LeMaitre Vascular, Inc., Getinge AB (Maquet), W. L. Gore & Associates, Inc., Edwards Lifesciences Corporation, Baxter International Inc., CryoLife, Inc., Medtronic, and Admedus, among others.
Insights from this report would allow marketers and management authorities of companies to make informed decisions regarding future drug launches, drug class up-gradation, market expansion, and marketing tactics
The global vascular patches market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vascular patches market.
Detailed Segmentation:
Global Vascular Patches Market, By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
Global Vascular Patches Market, By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
Global Vascular Patches Market, By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
Global Vascular Patches Market, By Region:
North America
By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Country:
U.S.
Canada
Latin America
By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Type:
Biologic Vascular Patches
Synthetic Vascular Patches
By Application:
Carotid Endarterectomy
Aortic Aneurysms
Profundaplasty
Others
By End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
B. Braun Melsungen AG *
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
C. R. Bard, Inc.
LeMaitre Vascular, Inc.
Getinge AB (Maquet)
W. L. Gore & Associates, Inc.
Edwards Lifesciences Corporation
Baxter International Inc.
CryoLife, Inc.
Medtronic
Admedus.
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook